» Articles » PMID: 28371427

Patients' Maximum Acceptable Waiting Time for Cataract Surgery: a Comparison at Two Time-points 7 years Apart

Overview
Journal Acta Ophthalmol
Specialty Ophthalmology
Date 2017 Apr 4
PMID 28371427
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the maximum acceptable waiting time (MAWT) of cataract patients and assess the determinants of their perception of MAWT at two time-points 7 years apart.

Methods: In 2007 (prior to the transformation of our cataract service to a day case unit) and 2014, 500 consecutive patients with cataract were asked to fill in a preoperative questionnaire addressing their MAWT to undergo cataract surgery. The patients' visual impairment (VF-14 score), education and social status were evaluated.

Results: The mean MAWT was 3.2 months in both periods, whereas the actual waiting time decreased significantly by 1.7 months (p < 0.001). Patients who had self-noted visual impairment were nearly four times (p < 0.001) more likely to accept only an MAWT of <3 months in 2007. In both periods, patients with a VF-14 score lower than the mean were more likely to accept a shorter MAWT (p = 0.002 and p = 0.034). Living together with children or having relatives close by was associated with a greater acceptance of an MAWT longer than 3 months (p = 0.002 and p = 0.023).

Conclusion: Reducing the actual mean waiting time had no impact on the mean MAWT. Patients with poor tolerance of waiting had greater self-reported difficulty with vision. Social support was also a strong predictor from the patients' perspective. The VF-14 score had a greater impact than clinical visual acuity (VA) testing. Considering the implementation of standards for waiting lists, objective criteria to guarantee a transparent system should be taken into account.

Citing Articles

Utility index and vision-related quality of life in patients awaiting specialist eye care.

Araujo A, Zanotto B, Beck da Silva Etges A, Ruschel K, de Campos Moreira T, Cezar Cabral F PLoS One. 2024; 19(8):e0307691.

PMID: 39133678 PMC: 11318885. DOI: 10.1371/journal.pone.0307691.


Rethinking Elective Cataract Surgery Diagnostics, Assessments, and Tools after the COVID-19 Pandemic Experience and Beyond: Insights from the EUROCOVCAT Group.

Tognetto D, Brezin A, Cummings A, Malyugin B, Kemer O, Prieto I Diagnostics (Basel). 2020; 10(12).

PMID: 33276612 PMC: 7761628. DOI: 10.3390/diagnostics10121035.